IDEAYA BIOSCIENCES, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$1.11B
↓-1.3% -$15Mvs FY2024
Total Liabilities
$86M
↑+33.0% +$21Mvs FY2024
Equity
$1.02B
↓-3.4% -$36Mvs FY2024
Cash
$113M
↑+33.7% +$28Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.11B | $1.12B |
| Current Assets | $667M | $690M |
| Cash | $113M | $84M |
| ST Investments | $527M | $592M |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $27M | $13M |
| Non-Current Assets | $443M | $434M |
| PPE | $8M | $9M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $410M | $406M |
| Other Non-Current | $24M | $20M |
| Total Liab+Eq | $1.11B | $1.12B |
| Current Liab. | $59M | $46M |
| Accounts Payable | $18M | $15M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $41M | $31M |
| Non-Current Liab. | $28M | $19M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $28M | $19M |
| Equity | $1.02B | $1.06B |
| Retained Earnings | $737M | $623M |
| Other Equity | $286M | $436M |
QuarterCharts · SEC EDGAR data · IDYA · Comparing FY2025 vs FY2024